- Active Substance: Andarine
- Concentration: 25 mg/cap
- Pack Size: 90 caps
- Manufacturer: Ultima Pharmaceuticals
- Brand Name: S4
SKU: P4053
Understanding Andarine (S4): A Pharmacological Overview
Andarine, also known as S4 or by its investigational name GTx-007, is a Selective Androgen Receptor Modulator (SARM) developed and researched by Ultima Pharmaceuticals. SARMs are being studied for their ability to selectively bind to androgen receptors, aiming to produce anabolic effects in muscle and bone tissues while minimizing impact on other organs, potentially leading to fewer side effects compared to traditional anabolic steroids.
Mechanism of Action (Pharmacological Perspective)
Andarine is under investigation for its partial agonist activity at androgen receptors. This means it binds to these receptors but may not activate them to the same degree as full agonists like testosterone. Research suggests that Andarine exhibits tissue-selective anabolic activity, with a focus on muscle and bone. Its partial agonistic nature is a key area of ongoing pharmacological study to understand its full effects and safety profile.
Potential Research Benefits (For Research Purposes Only)
- Investigated for promoting lean muscle mass development.
- Studied for its potential to enhance bone strength and density.
- Research into its potential for fat oxidation.
- Exploration of its effects on vision in specific research models.
Please note: The potential benefits listed above are based on preclinical and early-stage research and have not been fully established in humans. Andarine (S4) is currently not approved for human therapeutic use by regulatory authorities.
Usage Guidelines (For Research Purposes Only)
As a compound intended for research purposes, any information regarding its use is strictly within the context of laboratory and research settings. Dosage and administration protocols are highly variable depending on the specific research goals and experimental models. Any discussion of human dosage or administration is speculative and not recommended.
Potential Side Effects (Based on Research)
Research into the side effects of Andarine (S4) is ongoing. Some preclinical studies have reported potential side effects, including visual disturbances (e.g., a yellow tint to vision), which are believed to be dose-dependent and reversible. Other potential side effects associated with androgen receptor modulation may also occur. A comprehensive understanding of its long-term safety profile in humans requires further research.
FAQ
What is Andarine (S4)?
Andarine, also known as S4 or GTx-007, is a Selective Androgen Receptor Modulator (SARM) being researched by Ultima Pharmaceuticals for its selective effects on androgen receptors.
How does Andarine (S4) work?
Research suggests Andarine acts as a partial agonist at androgen receptors, exhibiting tissue-selective anabolic activity, particularly in muscle and bone.
What are the potential research benefits of Andarine (S4)?
Potential research benefits include promoting lean muscle mass, enhancing bone strength, and potential for fat oxidation. These are based on ongoing research and not established for human therapeutic use.
What are the potential side effects of Andarine (S4)?
Research has reported potential side effects such as visual disturbances (yellow tint). Other side effects related to androgen receptor modulation may also occur. Long-term safety in humans is still under investigation.
Important Note: Andarine (S4) is a research compound and is not approved for human therapeutic use by regulatory authorities. Information provided here is strictly for research and informational purposes only. It is not intended as a guide for personal use. The use of SARMs carries potential risks, and their long-term effects are not fully understood. Consult with qualified healthcare professionals for any health concerns.